Anand Bhaskar 4
4 · REATA PHARMACEUTICALS INC · Filed Aug 17, 2023
Insider Transaction Report
Form 4
Anand Bhaskar
VP, Chief Accounting Officer
Transactions
- Sale
Class A common stock
2023-08-15$169.06/sh−193$32,628→ 24,705 total - Sale
Class A common stock
2023-08-16$168.42/sh−210$35,368→ 24,495 total
Footnotes (1)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.